Put Options

6 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$7.52 - $11.9 $5,264 - $8,330
700 New
700 $7,000
Q1 2024

May 15, 2024

BUY
$8.04 - $16.03 $61,907 - $123,431
7,700 New
7,700 $105,000
Q2 2023

Aug 14, 2023

SELL
$4.95 - $8.4 $27,720 - $47,040
-5,600 Reduced 75.68%
1,800 $13,000
Q1 2023

May 15, 2023

BUY
$4.26 - $6.75 $11,076 - $17,550
2,600 Added 54.17%
7,400 $42,000
Q4 2022

Feb 14, 2023

SELL
$2.41 - $5.89 $38,319 - $93,651
-15,900 Reduced 76.81%
4,800 $28,000
Q3 2022

Nov 14, 2022

SELL
$3.15 - $5.24 $5,355 - $8,908
-1,700 Reduced 7.59%
20,700 $66,000

Others Institutions Holding ORIC

About Oric Pharmaceuticals, Inc.


  • Ticker ORIC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,576,700
  • Market Cap $336M
  • Description
  • ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment r...
More about ORIC
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.